CRE-Luc Reporter Cell Line - THP1

THP-1 is a comprehensively characterized human monocytic cell line originally isolated from the peripheral blood of a 1-year-old male patient with acute monocytic leukemia. Growing in suspension, THP-1 cells serve as a cornerstone model in immunology and pharmacological research due to their robust expression of monocyte biomarkers and their ability to differentiate into mature, adherent macrophage-like cells upon stimulation with agents like phorbol 12-myristate 13-acetate (PMA). The CRE-Luc Reporter Cell Line - THP1 advances this essential cellular model through the stable genetic integration of a firefly luciferase reporter gene, explicitly driven by a promoter containing multiple cAMP Response Elements (CRE). This targeted genetic engineering ensures that the cells express the luciferase enzyme specifically in response to the activation of the cAMP/PKA (Protein Kinase A) signaling cascade, a fundamental intracellular pathway frequently triggered by G-protein coupled receptor (GPCR) engagement. Crucially, the engineered reporter cells strictly maintain the biological identity, suspension growth dynamics, and robust differentiation capacity of the parental line, providing a biologically authentic and highly responsive platform for signal transduction research.

The dynamic, stimulus-responsive nature of the CRE-Luc THP1 cell line makes it an indispensable tool for high-throughput in vitro analytics and drug discovery. In standard laboratory environments, the dynamic bioluminescent output serves as a highly sensitive, real-time metric for quantifying intracellular cAMP fluctuations. This provides an optimal platform for the screening and characterization of novel GPCR agonists and antagonists, particularly those targeting Gs- and Gi-coupled receptors, as well as for evaluating phosphodiesterase (PDE) inhibitors. Because the cAMP signaling axis plays a critical role in regulating monocyte and macrophage immune functions—including inflammatory cytokine production and cellular polarization—this cell line is exceptionally valuable for investigating neuroimmune interactions and the immunomodulatory effects of various biochemical agents. By allowing researchers to accurately map complex intracellular signaling networks without relying on labor-intensive downstream diagnostic assays, this reporter line significantly accelerates the preclinical development of targeted pharmacological and immune therapeutics.